Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding notice stating information may not be up to date and directing users to status updates. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedShow glossary by default and minor labeling changes (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study data, eligibility criteria, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations section added with California sites; California locations list updated under v3.3.3.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page, with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange Detected- Revision history updated: added v3.3.1 and removed v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.